CNMD
CONMED CORPORATIONNYSEResearch view
Healthcare · Electromedical & Electrotherapeutic Apparatus · Small-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$1.4B
Enterprise Value$2.2B
Income$47.1M
Sales$1.4B
Book/sh$34.49
Cash/sh$1.36
Dividend TTM$0.60
Payout53%
Employees—
IPO—
Quick Ratio1.01
Current Ratio2.14
Debt/Eq0.78
EPS (ttm)$1.51
EPS this Y-64.5%
EPS past 3/5Y—
Sales past 3/5Y9.6%
EPS Y/Y TTM-64.5%
Sales Y/Y TTM5.2%
Shs Outstand29.95M
ROA2.0%
ROE4.6%
ROIC3.8%
Gross Margin54.6%
Oper. Margin7.5%
Profit Margin3.4%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$1.0B
2021
$1.0B
2022
$1.2B
2023
$1.3B
2024
$1.4B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.0B | $1.0B | $1.2B | $1.3B | $1.4B |
| Gross Profit | $568.0M | $571.2M | $676.2M | $733.0M | $750.5M |
| Operating Income | $109.7M | $70.1M | $120.6M | $200.3M | $102.6M |
| Net Income | $62.5M | $-80.6M | $64.5M | $132.4M | $47.1M |
| Diluted EPS | $1.94 | $-2.68 | $2.04 | $4.25 | $1.51 |
| Operating Cash Flow | $111.8M | $33.4M | $125.3M | $167.0M | $170.7M |
| Free Cash Flow | $96.9M | $11.6M | $106.3M | $153.9M | $150.9M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $19.8M against $170.7M operating cash
COMMUNITY · $CNMD0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Electromedical & Electrotherapeutic Apparatus
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.